AMRX
$18.71
▲ +2.35%09/18 O 18.12 H 18.81 L 18.06 C 18.71 ▲ +2.35%
Vol 6.6M RS 89
Vol 6.6M RS 89
RS rating89
Now vs pivot (%)−2.86%
Tightening (ATR ratio)1.33×
Volume dry-up0.90×
Up/down volume, net0.14
From 52-week high3%
forming
Amneal Pharmaceuticals, Inc. Class A Common Stock
AMRX · Pharmaceutical Preparations · $6.0B
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The four are not in order. That is a description of where the averages sit, not a view about what happens next.
The read
The base has run 7.4 weeks and fell 14% from its ceiling at its deepest. The pivot is $19.26, and the stock closed 2.9% below it. Its relative strength rating is 89.
Also on
Peers
Catalyst roadmap
- Earningstentativein 41dQuarterly earningsOct 29, 2026
- EarningstentativeLLY · competitorin 41dLLY reportsOct 29, 2026
Flagged by the market sweep
GappedTape · 2026-09-17
+8.6%
Unusual volumeTape · 2026-09-17
6.7 sigma
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
Amneal (AMRX) Surges 8.6%: Is This an Indication of Further Gains?Zacks Investment Research · 2 days ago
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray